key: cord-0998058-g22bg5tn
authors: Fidan, Vural; Akin, Okan; Koyuncu, Handan
title: Rised sudden sensorineural hearing loss during COVID-19 widespread
date: 2021-03-31
journal: Am J Otolaryngol
DOI: 10.1016/j.amjoto.2021.102996
sha: 20e30d6e070b38725f897b14b9e8ad754572f39c
doc_id: 998058
cord_uid: g22bg5tn

BACKGROUND: Sudden sensorineural hearing loss (SSNHL) is commonly encountered in otolaryngologic practice. SARS-CoV-2 infection is typically marked by respiratory symptoms although neurologic manifestations of the disease have also been described. OBJECTIVE: We want to measure the incidence and clinical aspects of persons exhibiting in otolaryngology clinic (OC) with SSNHL during the COVID-19 widespread and in the constant interval of previous year. METHODS: We retrospectively inspected the medical information for admissions to OC in Eskisehir, Turkey, during the COVID-19 widespread to describe the patients SSNHL. Clinical knowledge was saved for each subject and corresponded with that of SSNHL subjects demonstrating in 2019. RESULT: Between 1 April and 30 September 2020, 68 patients admitted to OC for SSNHL; in 2019, there were 41 subjects, for an incidence rate ratio of 8.5 per 100.000 (95% CI 1.02–2.92) for the 2020 cohort. Of the 2020 group, forty-one patients (60.3%) presented with active or recent symptoms consistent with COVID-19 infection, compared with four (9.8%) in 2019 (p < 0.001). Furthermore, subjects in 2020 group were younger (−15.5 years, p = 0.0141) than 2019 group and demonstrated prolonged interim (+1.7 days, p < 0.001) between SSNHL initiation and OC petition. CONCLUSION: We detected increased incidence of SSNHL during the COVID-19 widespread compared to the same interval of the prior year; 60.3% of subjects confronting with SSNHL had signs that were harmonious with COVID-19.

COVID-19 that is the name of the disease caused by the SARS-CoV2 virus remains to interrupt our lifes as pandemic in 2020 (1) . COVID-19 is usually noticed by fever, cough, sore throat, headache, muscle pain, diarrhea, and dyspnea, although neurological presentations of COVID-19 have also been defined (2, 3) . Some reports have published that COVID-19 could result cranial neuropathies such as anosmia and facial nerve palsy (4) (5) (6) .

Sudden sensorineural hearing loss (SSNHL) is a hearing loss of at least 30 dB within 3 days and intervention is established a course of corticosteroids and hyperbaric oxygen therapy (7, 8) . The absolute majority of patients with SSNHL have no diagnosed reason for hearing loss and are assorted as idiopathic but the correlation with viral contagion has been declarated (9).

Moreover, there are few SSNHL case reports due to COVID-19. The immune mediated mechanism has been published as a suitable hypothesis for cranial neuropathies also many viruses such as coronaviruse are acknowledged to be neurotropic hence there is the principle J o u r n a l P r e -p r o o f Journal Pre-proof to estimate a connection between COVID-19 and SSNHL (10, 11).

The purpose of this survey was to evaluate the change in the incidence and clinical aspects of subjects exhibiting with SSNHL during the COVID-19 widespread in Eskisehir to find associations between COVID-19 and SSNHL.

In this study, we retrospectively reexamined the medical documents of all patients with SSNHL between 1 April and 30 September 2020 and compared these findings with the medical documents of subjects with SSNHL 1 April and 30 September 2019.

The study was approved by the Local Ethical Committee.

For each subject, we assembled demographic and medical data. Also, we specifically examined the symptoms that the World Health Organization reported to be related to COVID-19 (fever, fatigue, myalgia, respiratory symptoms, headache, diarrhea, nausea or vomiting, loss of smell or taste) (12).

Official population data released in January 2019 and January 2020 were used to calculate the incidence of SSNHL.

The incidence meausres were corresponded by computing the risk ratio (RR) with affiliated 95% confidence intervals (95% CI). SPSS 20.0 for Windows was used for statistical analysis. 

COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Neurological manifestations and neuroinvasive mechanisms of the severe acute respiratory syndrome coronavirus type 2

COVID-19 presenting with ophthalmoparesis from cranial nerve palsy

Pearls and Oy-sters: Facial nerve palsy as a neurological manifestation of Covid-19 infection

Guillain-Barré syndrome in a patient with antibodies against SARS-COV-2

Corticosteroids for Bell's palsy (idiopathic facial